Usefulness of milnacipran in treating phantom limb pain

QR Code

Usefulness of milnacipran in treating phantom limb pain

Yasuhide Nagoshi,1 Akira Watanabe,1 Saiko Inoue,1 Tomoki Kuroda,2 Mitsuo Nakamura,3 Yoshitake Matsumoto,4 Kenji Fukui31Department of Psychiatry (Psychosomatic Medicine), Kyoto First Red Cross Hospital, Kyoto, Japan; 2Gojouyama Hospital, Nara, Japan; 3Department of Psychiatry, Graduate School of Medi...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Matsumoto Y, Nakamura M, Kuroda T, Inoue S, Watanabe A, Nagoshi Y, Fukui K
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2012
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/fae64bf68a9a4a25a2dda30805bcfa27
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Milnacipran: recent findings in depression
par: Guest editors: Stuart Montgomery (London, et autres
Publié: (2010)

Antidepressant therapy with milnacipran and venlafaxine
par: Lucilla Mansuy
Publié: (2010)

Milnacipran: a unique antidepressant?
par: Siegfried Kasper, et autres
Publié: (2010)

Effect of triiodothyronine (T3) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats
par: Kitaichi Y, et autres
Publié: (2012)

Phantom Limb Pain and Sensations in Chinese Malignant Tumor Amputees: A Retrospective Epidemiological Study
par: Jiang S, et autres
Publié: (2021)

Role and rationale for the use of milnacipran in the management of fibromyalgia
par: Jay D Kranzler, et autres
Publié: (2010)

Editorial Foreword - Milnacipran: recent findings in depression
par: Stuart Montgomery, et autres
Publié: (2010)

Improvement of the noradrenergic symptom cluster following treatment with milnacipran
par: Kasper S, et autres
Publié: (2011)

Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
par: Peter Hofmann
Publié: (2010)

Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
par: Alla Avedisova, et autres
Publié: (2009)

Effects of milnacipran on binge eating &ndash; a pilot study
par: Shun&rsquo;ichi Noma, et autres
Publié: (2008)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
par: Kamijima K, et autres
Publié: (2013)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
par: Kamijima K, et autres
Publié: (2013)

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression
par: Hisashi Higuchi,&nbsp;Hitoshi Takahashi, et autres
Publié: (2009)

Possible association between phantom vibration syndrome and occupational burnout
par: Chen CP, et autres
Publié: (2014)

Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
par: Philippe Courtet
Publié: (2010)

Rapid improvement of depressive symptoms in suicide attempters following treatment with milnacipran and tricyclic antidepressants &ndash; a case series
par: Kirino E, et autres
Publié: (2011)

Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)
par: Heidemarie Abrahamian, et autres
Publié: (2009)

&nbsp;Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group)
par: Abrahamian H, et autres
Publié: (2012)

Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain
par: Ogawa K, et autres
Publié: (2015)

Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study
par: Jean-Pierre Oli&eacute;, et autres
Publié: (2010)

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
par: Kudo S, et autres
Publié: (2015)

Assessment of anxiety and depression after lower limb amputation in Jordanian patients
par: Ziad M Hawamdeh, et autres
Publié: (2008)

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study
par: Hashimoto T, et autres
Publié: (2015)

Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity
par: Veauthier C, et autres
Publié: (2015)

Japanese version of the Munich Parasomnia Screening: translation and linguistic validation of a screening instrument for parasomnias and nocturnal behaviors
par: Komada Y, et autres
Publié: (2015)

Relationship between electrodiagnostic severity and neuropathic pain assessed by the LANSS pain scale in carpal tunnel syndrome
par: G&uuml;rsoy AE, et autres
Publié: (2013)

Life satisfaction in patients with chronic pain &ndash; relation to pain intensity, disability, and psychological factors
par: St&aring;lnacke BM
Publié: (2011)

Childhood adversities and laboratory pain perception
par: Pieritz K, et autres
Publié: (2015)

Post-traumatic stress in patients with injury-related chronic pain participating in a multimodal pain rehabilitation program
par: Britt-Marie St&aring;lnacke, et autres
Publié: (2010)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
par: Hongkaew Y, et autres
Publié: (2015)

Help-seeking behavior among Japanese school students who self-harm: results from a self-report survey of 18,104 adolescents
par: Furukawa TA, et autres
Publié: (2012)

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
par: &Uuml;nsal C, et autres
Publié: (2013)

Duloxetine in panic disorder with somatic gastric pain
par: Preve M, et autres
Publié: (2013)

Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy
par: Tanamachi Y, et autres
Publié: (2015)

Defensive function of persecutory delusion and discrepancy between explicit and implicit self-esteem in schizophrenia: study using the Brief Implicit Association Test
par: Nakamura M, et autres
Publié: (2014)

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
par: Nakagawa R, et autres
Publié: (2015)

Reduced dorsolateral prefrontal cortical hemodynamic response in adult obsessive-compulsive disorder as measured by near-infrared spectroscopy during the verbal fluency task
par: Hirosawa R, et autres
Publié: (2013)

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
par: Takahashi M, et autres
Publié: (2012)

Clinical use of pregabalin in the management of central neuropathic pain
par: Nanna B Finnerup, et autres
Publié: (2007)